Unfinished Business in Preventing Alzheimer Disease

JAMA Intern Med. 2016 Dec 1;176(12):1739-1740. doi: 10.1001/jamainternmed.2016.6310.

Authors

Jason Karlawish¹, Kenneth M Langa²

Affiliations

¹ Perelman School of Medicine, Departments of Medicine, Medical Ethics and Health Policy, and Neurology, Penn Program for Precision Medicine for the Brain, University of Pennsylvania, Philadelphia.
² Institute for Social Research, Institute for Healthcare Policy and Innovation, Department of Internal Medicine, University of Michigan, Ann Arbor3Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adult
Aged
Aged, 80 and over
Alzheimer Disease / drug therapy
Alzheimer Disease / prevention & control*
Clinical Trials as Topic
Cognitive Dysfunction / drug therapy*
Drug Approval / legislation & jurisprudence*
Humans
Middle Aged

Grants and funding